Peri-Operative Changes of Inflammatory Markers and Their Implications in Pulmonary Endarterectomy

TL;DR

This paper reviews how inflammatory markers change before and after pulmonary endarterectomy surgery and their possible significance.

Contribution

The study compiles recent data on inflammatory markers during pulmonary endarterectomy to explore their potential implications.

Findings

Levels of inflammatory factors change during the peri-operative period of PEA.

The specific role of these inflammatory markers remains unclear but may be relevant.

The study aims to understand the potential implications of these changes.

Abstract

Pulmonary endarterectomy (PEA) is used to
treat chronic thromboembolic pulmonary hypertension (CTEPH) patients, and it can
effectively remove organized thrombotic materials and proliferative intima as
well as improve hemodynamics. It has been reported that the levels of several
inflammatory factors were altered in the peri-operative period of
PEA. Even though their specific role remains unknown, this could
have some relevance. In this study, we reviewed the recently published data
addressing these factors in PEA, attempting to understand their potential
implications.

Figures